Search - tctmd.com

Displaying 321 - 340 of 546

Sort: Relevancy | Date

News Daily News

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Todd Neale

October 04, 2017

News Daily News

Women Receive Less Aggressive CABG Compared With Men

Yael L. Maxwell

September 29, 2017

News Daily News

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

L.A. McKeown

August 16, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

July 28, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Conference News EuroPCR 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Yael L. Maxwell

May 18, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

News Daily News

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

L.A. McKeown

April 17, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

News Industry News

Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs

March 21, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Conference News ACC 2017

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Michael O'Riordan

March 10, 2017

Advertisement

Vast Majority Return to Work After MI, but It Doesn’t Always Stick

Women Receive Less Aggressive CABG Compared With Men

Off-Pump CABG Linked to Higher Long-term Mortality in ROOBY-FS

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

STENTYS Completes Enrollment in the Study Assessing the Safety and Efficacy of Xposition S in Left Main Artery Lesions

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

The Left Main Debate: What Does it Mean for the Future of Intervention?

REVA to Expand FANTOM II Trial to More Complex Cases

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Siemens Healthineers and HeartFlow Collaborate to Provide Solution That Has Potential to Lower Cardiac Care Costs

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content